BioNTech Investor Presentation Deck

Multi-platform Strategy: Toolbox for Innovation 14 RIBOLYSINS Precision antibacterials (Phagomed) Internal technology Acquisition Collaboration Digital & Al capabilities INDIVIDUALIZED mRNA CANCER VACCINES iNeST INFECTIOUS DISEASES VACCINES • Prophylactic vaccines • Therapeutic vaccines *mRNA encoded cancer-targeting antibodies and cytokines OFF-THE-SHELF mRNA CANCER VACCINES FixVac mRNA TECHNOLOGY LIPID- NANOCRYSTAL- FORMULATIONS (Matinas) ARTIFICIAL INTELLIGENCE • mRNA Drug Design Early SARS- CoV-2 variant detection RIBO- LOGICALS* RiboCytokines • RiboMabs CARVac mRNA Vaccine boosted CAR-T cells PERSONA- LIZED TCR- THERAPY MULTI-TARGET TCR RESEARCH COLLABORATION (Medigene) CELL & GENE THERAPIES INDIVIDUALIZED NEOANTIGEN T CELL THERAPY mRNA ENCODED HUMABODIES (Crescendo) SOLID TUMOR CAR-T Ideal CAR-T cell targets NEXT GEN IMMUNE CHECKPOINT MODULATORS Bispecific antibodies ANTIBODIES SMALL MOLECULES TARGETED CANCER THERAPIES SELECTIVE TLR-7 ANTAGONISM BIONTECH

View entire presentation